LT
Lapix Therapeutics Inc.
SEC filingOther Technology · Cambridge, MA
Amount raised$2.2Msold at filing
Total offering$5M$2.8M still open
Investors in the raise10count reported to the SEC
FiledAug 5, 2025first sale Jul 21, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Anas FathallahExecutive Officer, Director
Anthony GibneyDirector
Jason NorrisExecutive Officer, Director
Francisco LeonDirector
Henry McKinnellDirector
Executive officers, directors and promoters as listed on the Form D.